No Data
No Data
No Data
No Data
No Data
UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting
SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. ("UNITY") [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases
GlobeNewswireApr 25 20:00
UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME
PDF Version SOUTH SAN FRANCISCO, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. ("UNITY") [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or r
Unity BiotechnologyApr 24 08:00
Unity Biotechnology Adds More Patients, Extends Length of Trial of Prospective Macular Edema Treatment
Unity Biotechnology (UBX) early Tuesday said phase 2b testing of its UBX1325 drug candidate has been extended by an extra 12 weeks allowing researchers to compare the drug's durability with aflibercep
MT NewswiresApr 23 22:37
UNITY Biotechnology Announces Extension Of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 For Patients In Diabetic Macular Edema
UNITY Biotechnology Announces Extension Of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 For Patients In Diabetic Macular Edema
BenzingaApr 23 20:02
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. HC Wainwri
BenzingaApr 17 20:21
Unity Biotechnology Is Maintained at Buy by HC Wainwright & Co.
Unity Biotechnology Is Maintained at Buy by HC Wainwright & Co.
Dow JonesApr 16 19:15
No Data
No Data